Trials / Completed
CompletedNCT05444803
Femoral Nerve Block vs Peri-capsular Nerve Group Block for Hip Fracture Analgesia
Comparison of Femoral Nerve Block Versus Peri-capsular Nerve Group Block for Analgesia During Positioning for Spinal Anesthesia in Patients With Hip Fracture
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 52 (actual)
- Sponsor
- Antalya Training and Research Hospital · Other Government
- Sex
- All
- Age
- 18 Years – 85 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to compare the analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia
Detailed description
Spinal anesthesia is commonly used in patients undergoing hip fracture surgery. However the procedure of patient positioning to perform a spinal block is painful and may require the administration of IV analgesics or some regional anesthesia techniques such as femoral nerve block, fascia-iliaca compartment block, peri-capsular nerve group block. At the study, the investigators aimed to compare analgesic efficacy of femoral nerve block and peri-capsular nerve group block administered before spinal anesthesia for positioning to spinal anaesthesia in patients undergoing surgery for hip fracture and to evaluate the efficacy for postoperative analgesia.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | femoral nerve block | Patients will be performed a femoral nerve block using bupivacaine thirty minutes before the performing of spinal block. |
| OTHER | peri-capsular nerve group block | Patients will be performed a peri-capsular nerve group block using bupivacaine thirty minutes before the performing of spinal block. |
Timeline
- Start date
- 2022-07-06
- Primary completion
- 2022-11-07
- Completion
- 2022-12-19
- First posted
- 2022-07-06
- Last updated
- 2023-03-13
Locations
1 site across 1 country: Turkey (Türkiye)
Source: ClinicalTrials.gov record NCT05444803. Inclusion in this directory is not an endorsement.